Interwell Health
PrivateLast Round
M&A
Aug 24, 2022
Est. Valuation
$2.4B
Total Funding Raised
$46.1M
Momentum Score
25 /100
Company Overview
Interwell Health is a kidney care management company that provides value-based care services. The current company was formed in August 2022 through a three-way merger of Fresenius Health Partners, the legacy InterWell Health network, and Cricket Health. It partners with over 2,000 nephrologists to manage patient care across the full continuum of chronic kidney disease (CKD), from early stages to end-stage kidney disease. The company utilizes predictive analytics and machine learning to identify at-risk patients, enabling early intervention to slow disease progression and improve health outcomes. Interwell Health operates in all 50 states and is a major participant in the Centers for Medicare and Medicaid Services (CMS) Kidney Care Choices (KCC) program, aiming to reduce healthcare costs while improving the quality of life for patients.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Patient Engagement, EHR & EMR, Telemedicine, Revenue Cycle
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Interwell Health Comps
Public and private peers based on sector, stage, and business model.
Interwell Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Aug 24, 2022 | ||||
| Series B | Apr 22, 2021 |
Key People
Founding team and executive leadership
Interwell Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oak HC/FT | M&A |
| Blue Shield of California | M&A |
| Cigna Ventures | M&A |
| Valtruis | M&A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 26, 2026
Carney Taylor appointed to lead clinical strategy and quality initiatives.
- Oct 1, 2025
Tommy P. O'Connor named new CEO and Value-Based Care leader.
Interwell Health Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Interwell Health's valuation, stock price, and market status.
